Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.
Imeglimin is a universal anti-diabetic drug that incorporates the power of all existing glucose-lowering drugs.
Finerenone for the treatment of diabetic nephropathy, a chronic kidney disease associated with type 2 diabetes mellitus.
Redasemtide as a lifesaver for the most devastating diseases, including stroke, osteoarthritis, cardiomyopathy, and bullous epidermolysis.
Two injections of inclisiran a year and you can forget about high cholesterol. Novartis doesn’t lie.
Arterial hypertension is waiting for a major pharmacological breakthrough. Hundreds of millions of people will be saved.
Novo Nordisk’s newest drug did well in treating obesity and overweight.